The program is still filling in: the organizers list three tracks as under development and many talk titles as to be confirmed. We’ll add new sessions and the organizations presenting them as the agenda grows.

Who’s Going to World Vaccine Congress 2027

Mar 8–11, 2027 Washington, DC ~3k attendees Website

222 organizations and 185 speakers at World Vaccine Congress 2027, a ~3,000-person, mostly industry meeting of vaccine R&D, manufacturing and regulatory leaders. As of Oct 8, 2026.

Format
Topic
Top represented
Showing 1–14 of 222 organizations
OrganizationWorld Vaccine Congress 2027 Attendance
CEPI
Oslo, Norway
Public health & non-profit
Coalition for Epidemic Preparedness Innovations: global partnership funding vaccines against emerging infectious diseases and epidemic threats.
Talk
Wed Mar 10
09:10
CEPI Correlates of Protection Updates
Immune Profiling Track
Panel
Wed Mar 10
09:10
Panel: Analytical Innovation
Bioprocessing & Manufacturing Track
Talk
Wed Mar 10
16:40
Deep Dive Session: Non-animal preclinical systems for vaccine development and pandemic preparedness
How organoids and organ-on-chip systems could replace some animal studies in early vaccine testing and pandemic preparedness.
with Wyss Institute at Harvard University
Sanofi
Paris, France
Large pharmaBronze sponsor
Global pharmaceutical company with a large vaccines business spanning influenza, pediatric, meningitis and mRNA programs.
Booth
Exhibiting (no floor booth listed)
Chair
Wed Mar 10
09:00
Chair’s opening remarks
Influenza & Respiratory Diseases Track
Panel
Wed Mar 10
09:10
Panel: Pharma Ready: What It Really Takes to Seal the Deal
What large drug companies look for before partnering with a young vaccine company, from manufacturing readiness and patents to timing the conversation.
with Omniose, Vaxcyte, Eli Lilly
Talk
Wed Mar 10
15:40
Sanofi Respiratory Vaccine Pipeline Updates
Influenza & Respiratory Diseases Track
Pfizer
New York, NY
Large pharma
Global pharmaceutical company with a vaccine portfolio spanning pneumococcal, RSV, COVID-19 and other infectious diseases.
Keynote
Tue Mar 9
14:55
The Longevity Dividend: Scaling Adult Immunization for an Aging Global Population
How vaccines for older adults can overcome age-related immune decline and a crowded adult schedule, and how to raise low uptake worldwide.
with Africa CDC
Clinical & preclinical developmentSupply, safety & access
Talk
Wed Mar 10
15:10
Pfizer Respiratory Vaccine Pipeline Updates
Influenza & Respiratory Diseases Track
Talk
Wed Mar 10
16:40
Strategies for large scale vaccinations for the world – multidose vial and CMC challenges
Bioprocessing & Manufacturing Track
Academic
Pediatric teaching hospital of Harvard Medical School, home to the Precision Vaccines Program.
Talk
Mon Mar 8
10:00
Vaccine Technology Workshop
New vaccine technologies, from machine learning that pairs adjuvants with antigens to self-amplifying RNA and a liposome-adjuvanted malaria vaccine.
with Montani Biotechnologies, Arcturus Therapeutics, Akagera Medicines +2 more
Talk
Wed Mar 10
09:10
Vaccine Safety Track: sessions to be announced
with Johns Hopkins Bloomberg School of Public Health, Brighton Collaboration, Global Vaccine Data Network +1 more
Academic
Research university whose Perelman School of Medicine pioneered the modified mRNA used in COVID-19 vaccines.
Talk
Mon Mar 8
10:00
AMR Workshop
How vaccines, antibodies and phage therapy can be developed, funded and used against drug-resistant bacteria, from infant infections to livestock.
with Omniose, AMR Strategic Coalition, Gates Foundation +6 more
Talk
Wed Mar 10
12:30
The Exemption Expansion: Mandate Trends Under Trump II
Vaccine Access Track
Talk
Thu Mar 11
09:40
Protective Pan-Betacoronavirus Neutralizing Antibodies by Vaccination
Pandemic Platforms Track
Eli Lilly
Indianapolis, IN
Large pharma
Global pharmaceutical company whose medicines span diabetes, obesity, oncology, immunology and neuroscience, with antibody research against infectious diseases.
Talk
Mon Mar 8
10:00
Antibodies for Infectious Diseases Workshop
Research on antibody medicines that treat or prevent infectious diseases.
with AstraZeneca, ModeX Therapeutics, GigaGen
Panel
Wed Mar 10
09:10
Panel: Pharma Ready: What It Really Takes to Seal the Deal
What large drug companies look for before partnering with a young vaccine company, from manufacturing readiness and patents to timing the conversation.
with Omniose, Vaxcyte, Sanofi
CRO, CDMO & labsSilver sponsor
Integrated network of US clinical research sites with a long track record in vaccine trials.
Booth
Exhibiting at Booth 204
Consulting & services
US law firm focused on health care and life science law, including regulatory and employment matters.
Keynote
Thu Mar 11
13:40
Keynote fireside chat
Keynotes · with Clinton Foundation
Public health & non-profit
International non-profit organization developing and delivering vaccines for global health.
Keynote
Tue Mar 9
09:30
Keynote Panel: Are We Ready for the Next Outbreak? Reconciling Surveillance, Diagnostics, and the MCM Pipeline
How surveillance, diagnostics and regulators can work together to get vaccines deployed quickly in sudden outbreaks of viruses like Ebola and Marburg.
with ACEGID, PATH, Africa CDC
Infectious disease & AMR
Moderna
Cambridge, MA
Large pharma
mRNA medicines company with marketed vaccines against COVID-19 and RSV, and mRNA candidates for influenza, other infections and cancer.
Chair
Wed Mar 10
09:00
Chair’s opening remarks
Vaccine Safety Track
Callen-Lorde
New York, NY
Academic
Community health center providing primary care and sexual health services to LGBTQ communities in New York City.
Talk
Mon Mar 8
10:00
HIV Vaccines Workshop
Where the search for an HIV vaccine stands, from laboratory advances and ongoing clinical trials to plans for fair global access.
with Fred Hutch, IAVI, ModeX Therapeutics
Keynote
Thu Mar 11
14:20
Closing Keynote: Reimagining public health infrastructure in the USA – opportunities to rebuild with intention
How the US could rebuild its public health system for the long term, from disease forecasting and biodefense to universal vaccine access.
with Infectious Diseases Society of America, Manatt Health
Supply, safety & access
Academic
Argentine public university whose researchers developed ARVAC, a recombinant protein COVID-19 vaccine.
Talk
Wed Mar 10
12:40
360biolabs
Melbourne, Australia
CRO, CDMO & labs
Australian specialist laboratory running virology, immunology and serology assays for vaccine and infectious disease trials.
Booth
Exhibiting at Booth 357
Panel
Wed Mar 10
14:40
Panel: From Lab Bench to Bedside: Accelerating the Clinical Journey
Clinical Trials Track · with Biointelect, CBE Pure Solutions, Paratus Clinical +1 more
Reagents, assays & analyticsBronze sponsor
Swedish company supplying immunoassays and instruments for ELISpot, FluoroSpot, ELISA and multiplex analysis.
Booth
Exhibiting at Booth 377
Talk
Wed Mar 10
10:10

Explore the full World Vaccine Congress 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from companies at World Vaccine Congress 2027

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

When and where is World Vaccine Congress 2027?

World Vaccine Congress Washington 2027 runs March 8–11, 2027, at the Walter E. Washington Convention Center in Washington, DC.

Where is the World Vaccine Congress 2027 program?

This guide lists every organization on the World Vaccine Congress 2027 program with its sessions; the full program is on the official website.

How do I register for World Vaccine Congress 2027?

Fees and registration are on the organizer's registration page.

What conference is this?

The World Vaccine Congress Washington is the World Vaccine Congress series’ flagship annual meeting, held March 8–11, 2027 at the Walter E. Washington Convention Center in Washington, DC, with pre-congress workshops on March 8. It brings together vaccine R&D, clinical, manufacturing, regulatory and public-health leaders from industry, government, academia and global health with the CROs, CDMOs and suppliers that serve them, across tracks on influenza and respiratory diseases, emerging diseases, pandemic platforms, cancer and immunotherapy, clinical trials, immune profiling, bioprocessing and manufacturing, vaccine access, safety, supply and logistics, partnerships, and veterinary and One Health.

What is in this guide?

Every organization we can place at World Vaccine Congress 2027: 185 speakers from the public program and speaker list (60 sessions so far) rolled up to their companies and institutions, plus the 107 sponsors and exhibitors from the public listing and floor plan with their stand numbers where published — 222 organizations in one list. Speakers appear as job titles, never by name.

How are organizations typed?

By the role an organization plays in vaccine development: vaccine and drug developers (large pharma and biotech), then the companies around them — CROs, CDMOs and testing labs, bioprocess and manufacturing suppliers, reagents, assays and analytics, software, consulting and other services — and academic and public-health bodies. The topic filters come from the track a session sits in, and for keynotes from the session’s own title and description.

How current is it?

Pulled from the public agenda, speaker list, sponsor and exhibitor listing and floor plan on October 8, 2026, five months before the meeting. The agenda is still filling in, so more sessions and speakers will follow. Stand numbers come from the organizer’s floor plan; the exhibition’s opening hours are not published yet.

Browse World Vaccine Congress 2027 by

Exhibit hall

Organizations with their own page

120 organizations — every exhibitor and every organization with 2 or more presentations.

Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction